Health Health

GE HealthCare in its agreement to acquire Intelerad for US$2.3 billion

On November 20, 2025, GE Healthcare Technologies Inc., a leading global healthcare solutions provider, announced it has entered into an agreement to acquire Intelerad for a purchase price of US$2.3 billion in cash. Intelerad, which has operations in Canada and the U.S., is a leading medical...

Lead Office: Toronto Date Announced: November 20, 2025 Value: US$2.3 billion

Felix Health in its $53-million growth financing

On October 23, 2025, Felix Health announced that it secured $53 million of growth financing from the Canadian Business Growth Fund (CBGF) and other existing investors. The capital will be used towards the growth of personalized health options for Canadians. Felix Health Inc. is a patient-driven...

Lead Office: Toronto Date Announced: October 23, 2025 Value: $53 million

EllisDon and PCL Healthcare Partners awarded fixed price contract of $13.9 billion for The Peter Gilgan Mississauga Hospital and Shah Family Hospital for Women and Children

On July 10, 2025, EllisDon and PCL Healthcare Partners, through the Trillium M Project Co General Partnership, entered into an agreement with Trillium Health Partners to design, build, finance and maintain the Peter Gilgan Mississauga Hospital and Shah Family Hospital for Women and Children, in...

Lead Office: Toronto Date Announced: July 10, 2025 Value: $13.9 billion

Novari Health Inc. in its acquisition by VitalHub Corp.

On July 7, 2025, Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (VitalHub) announced it has acquired Novari Health Inc. (Novari) for $43.6 million, plus potential performance-based consideration. The purchase price paid at closing was composed of a cash payment of $35.8 million, subject to working...

Lead Office: Montreal Date Announced: July 7, 2025 Value: $48.6 million

iGan Partners in connection with Cosm Medical’s Seed financing round

On June 5, 2025, Cosm Medical announced it raised an undisclosed amount in a Seed financing round led by iGan Partners. The company plans to utilize the new capital towards its expansion plans to the United States, clinical validation and commercial growth. iGan Partners is a Toronto-based...

Lead Office: Toronto Date Announced: June 5, 2025 Value: --

PurposeMed in its growth financing round led by True North Fund

On March 4, 2025, PurposeMed announced the successful completion of its growth financing round led by True North Fund, with major participation by BDC and Panache Ventures. PurposeMed is a Calgary-based, high-growth digital health company that provides accessible and specialized healthcare...

Lead Office: Vancouver Date Announced: March 4, 2025 Value: --

KisoJi in its raising of $57-million Series B financing

On December 6, 2024, KisoJi announced it raised $57 million of Series B financing. This round was co-led by Investissement Québec and Lumira Ventures. The round also saw participation from Fonds de solidarité FTQ, adMare BioInnovations and Remiges Ventures. The company plans on utilizing the...

Lead Office: Montreal Date Announced: December 6, 2024 Value: $57 million

Healthkind in its closing of a $1.26-million Seed financing round

On December 2, 2024, Healthkind  announced the closing of a $1.26-million Seed financing round through BDC’s $100-million social impact fund for women-led businesses. This financing will be utilized towards the company’s goal of patient-clinic communications. Healthkind operates as a...

Lead Office: Toronto Date Announced: December 2, 2024 Value: $1.26 million

ELNA Medical Group Inc. and certain of its subsidiaries in its court-approved Sale and Investment Solicitation Process (SISP) under the Companies’ Creditors Arrangement Act

In December 2024, ELNA Medical Group Inc. and certain of its subsidiaries obtained creditor protection, initiated proceedings and launched a court-approved Sale and Investment Solicitation Process (SISP) under the Companies’ Creditors Arrangement Act. As part of the SISP, ELNA Medical Group Inc....

Lead Office: Montreal Date Closed: -- Value: --

Flosonics Medical’s US$20-million Series C funding round with participation from iGan Partners and Genesys Capital

On March 20, 2024, Flosonics Medical announced it raising of US$20 million in a Series C financing round. This round was led by New Leaf Venture Partners and saw participation from Genesys Capital, iGan Partners and Arboretum Ventures. Flosonics Medical will utilize the funding towards product...

Lead Office: Toronto Date Announced: March 20, 2024 Value: $20 million